Enrolling by invitation NCT06910696
Erector Spinae Plane Block Versus Modified Thoracolumbar Interfascial Plane Block
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Regional Anesthetic Injection, Regional Anesthetic Injection.
- Who it may be relevant to
- Registry conditions: Achievement of High-quality Analgesia, Rapid Recovery With Rehabilitation in Lumber Spine Discectomy. Basic parameters: 21 years — 64 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Erector Spinae Plane Block Versus Modified Thoracolumbar Interfascial Plane Block for Rapid Recovery and Rehabilitation After Lumber Discectomy: A Randomized Study
Overview
the purpose of this study is to compare of better postoperative analgesia following lumber spine discectomy
Interventions
- Drug Regional Anesthetic Injection
The probe will be placed in the parasagittal plane at the level of the L3 vertebrae. The spinous process will be visualized, and the probe was moved 3 cm laterally from the midline. The erector spinae musclewill be visualized above the transverse process. The needle will be punctured in the craniocaudal direction using the in-plane technique. The needle will be directed superior to the transverse process . Then, 2 mL normal saline solution will be injected into the deep fascia of the erector spi - Drug Regional Anesthetic Injection
The probe will be placed vertically at the L3 vertebrae level. The spinous process and the interspinous muscles (i.e., multifidus, longissimus, and iliocostalis) will be visualized as the anatomic guide points. The probewill be moved laterally to identify the longissimus and iliocostalis muscles . The needlewill be inserted between the longissimus and iliocostalis in the medial-to-lateral direction using the in-plane technique. After confirming the location of the needle, 20 mL of 0.25% bupivaca
Primary outcome measures
- Length of hospital stay [Time frame: up to 1 weak postoperative.]
Secondary outcome measures (8)
- The recovery time [Time frame: up to 30 minutes postoperative.]
- The time of discharge [Time frame: up to 2 hours postoperative.]
- 6 minutes walk test [Time frame: 24 hours postoperative]
- Functional reach test [Time frame: 24 hours postoperative]
- Time up and go test [Time frame: 24 hours postoperative]
- Pain intensity [Time frame: 30 minutes after the end of the surgery, as well as 3, 6, 12, and 24 hours postoperatively]
- Time to first call analgesia [Time frame: 24 hours postoperative]
- Total naluphine consumption [Time frame: 24 hours post-operative]
Eligibility criteria
Inclusion criteria
- Written informed consent from the patient.
- Physical status: ASA 1\& II.
- BMI = (25-30 kg/m2).
- Type of operation: elective Lumbar discectomy .
Exclusion criteria
- Altered mental state.
- Patients with known history of allergy to study drugs.
- Advanced hepatic, renal, cardiovascular, and respiratory diseases.
- Patients with chronic pain.
- Patients receiving anticoagulants.
- Contraindications of regional anesthesia, e.g., allergy to local anesthetics, coagulopathy, or septic focus at site of injection.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- faculty of medicine,zagazig university Egypt Ext. 002 K.Howida@yahoo.com — Zagazig
Identifiers
NCT: NCT06910696 · ZU-IRB#1074/25-Feb-2025